Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma.

J Clin Invest · 2026 · PMC12867156 · PMID 41623182

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, the central coverage (defined as the bottom peak value) between subgroups showed a trend toward lower values for tRCC samples with a tumor fraction > 3% ( Supplemental Figure 5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.